S&P 500 7,723.39 ▲ 46.62 (+0.61%) DOW 52,389.06 ▲ 27.48 (+0.05%) NASDAQ 26,480.43 ▲ 311.05 (+1.19%) US Markets Closed â€ĸ 06:35 PM ET

PHG

Koninklijke Philips N.V.

Price Chart
Latest Quote

$26.57

-0.32 (-1.19%)
Current Price
Previous Close $26.89
Open $26.73
Day High $26.95
Day Low $26.49
Volume 2,041,908
Fetched: 2026-10-27T12:08:22
Stock Information
Note: Financial values converted from EUR to USD
Quarterly Dividend / Yield $1.01 / 3.81%
Shares Outstanding 977.43M
Quarterly Dividend Yield 3.81%
Quarterly Dividend $1.01
Total Debt $8.31B
Cash Equivalents $1.99B
Revenue $19.67B
Net Income $1.24B
Sector Healthcare
Industry Medical Devices
Market Cap $25.81B
P/E Ratio 19.86
EPS (TTM) $1.33
Exchange NYQ
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$31.68B
Sales$19.67B
Income$1.24B
Book/sh$13.16
Cash/sh$1.83
Employees64K
Financial Ratios
Quick Ratio0.73
Current Ratio1.26
Debt/Eq65.05
EPS Growth TTM60.00%
Returns & Margins
ROA4.07%
ROE10.15%
Gross Margin45.94%
Operating Margin13.99%
Profit Margin6.31%
Ownership
Institutional Ownership5.40%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E13.95
PEG0.82
P/S1.46
P/B2.01
Analyst Data
Recommendationnone
Target Price$32.02
Technical Indicators
SMA20$25.16
SMA50$25.54
SMA200$26.80
RSI79.44
ATR0.4604
Shares Float976.80M
Short Ratio3.30
Volatility0.92
Rel Volume1.05
Performance History
Week+1.58%
Month+5.18%
Quarter+1.19%
6 Months+1.18%
YTD+1.36%
Year-4.82%
3 Years+56.39%
5 Years-33.87%
10 Years+7.54%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-10-27 $26.41 1,424,445
2026-10-26 $26.57 2,041,900
2026-10-23 $26.89 1,342,700
2026-10-22 $26.92 1,192,000
2026-10-21 $26.23 938,900
2026-10-20 $26.00 800,300
2026-10-19 $25.50 1,114,600
2026-10-16 $25.74 1,338,600
2026-10-15 $25.49 1,225,500
2026-10-14 $25.00 1,105,800
2026-10-13 $24.89 982,700
2026-10-12 $24.74 1,213,000
2026-10-09 $24.24 3,330,700
2026-10-08 $24.30 1,635,100
2026-10-07 $24.09 1,443,400
2026-10-06 $24.15 1,386,600
2026-10-05 $23.91 1,160,500
2026-10-02 $23.92 836,300
2026-10-01 $23.81 1,336,000
2026-09-30 $24.43 1,185,700
2026-09-29 $24.77 816,200
2026-09-28 $25.11 835,600
About Koninklijke Philips N.V.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

📰 Latest News
No news articles available at the moment. Check back later for updates on PHG.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $10,962,098,618 $11,491,365,245 $12,021,753,200 $11,923,076,371
Cost Of Revenue $10,962,098,618 $11,491,365,245 $12,021,753,200 $11,923,076,371
Total Revenue $19,997,756,418 $20,207,444,680 $20,373,401,164 $19,989,907,125
Operating Revenue $19,579,501,224 $19,810,494,709 $19,936,083,400 $19,551,468,034
Expenses
Interest Expense $329,670,314 $377,887,401 $343,126,246 $273,603,934
Total Expenses $18,372,952,726 $19,632,203,621 $20,561,784,201 $20,188,382,110
Other Income Expense $-56,066,380 $-149,136,571 $-103,162,139 $-1,493,608,363
Net Non Operating Interest Income Expense $-242,206,762 $-288,181,193 $-298,273,142 $-250,056,055
Total Other Finance Cost $5,606,638 $-1,121,328 $6,727,966 $4,485,310
Interest Expense Non Operating $329,670,314 $377,887,401 $343,126,246 $273,603,934
Operating Expense $7,410,854,108 $8,140,838,376 $8,540,031,002 $8,265,305,740
Other Operating Expenses $-68,400,984 $498,990,782 $666,068,594 $-13,455,931
Selling And Marketing Expense $4,868,804,439 $5,030,275,614 $5,072,886,062 $5,181,654,840
General And Administrative Expense $704,193,733 $652,612,663 $681,767,181 $752,410,820
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $1,008,073,512 $-946,400,494 $-511,325,386 $-1,817,672,040
Net Interest Income $-242,206,762 $-288,181,193 $-298,273,142 $-250,056,055
Interest Income $93,070,191 $88,584,880 $51,581,070 $28,033,190
Normalized Income $1,043,197,978 $-938,912,269 $-516,909,597 $-423,245,103
Net Income From Continuing And Discontinued Operation $1,003,588,202 $-787,171,975 $-522,538,662 $-1,803,094,781
Total Operating Income As Reported $1,596,770,502 $593,182,300 $-128,952,674 $-1,714,509,900
Net Income Common Stockholders $1,003,588,202 $-787,171,975 $-522,538,662 $-1,803,094,781
Net Income $1,003,588,202 $-787,171,975 $-522,538,662 $-1,803,094,781
Net Income Including Noncontrolling Interests $1,005,830,857 $-782,686,665 $-519,174,679 $-1,799,730,798
Net Income Discontinuous Operations $-4,485,310 $159,228,519 $-11,213,276 $14,577,259
Net Income Continuous Operations $1,010,316,168 $-941,915,184 $-509,082,730 $-1,814,308,057
Pretax Income $1,325,409,223 $137,923,295 $-589,818,318 $-1,941,018,076
Special Income Charges $-26,911,862 $17,941,242 $59,430,363 $-1,514,913,588
Earnings From Equity Interest $-10,091,948 $-139,044,622 $-109,890,105 $-2,242,655
Interest Income Non Operating $93,070,191 $88,584,880 $51,581,070 $28,033,190
Operating Income $1,624,803,692 $575,241,059 $-188,383,037 $-198,474,985
Gross Profit $9,035,657,801 $8,716,079,435 $8,351,647,965 $8,066,830,754
Per Share
Diluted EPS $1.05 $-0.84 $-0.55 $-1.89
Basic EPS $1.05 $-0.84 $-0.55 $-1.89
Other
Tax Effect Of Unusual Items $-10,849,966 $-2,603,723 $1,143,754 $-96,938,771
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $2,961,426,192 $2,083,426,681 $1,160,574,066 $1,620,318,382
Total Unusual Items $-45,974,432 $-10,091,948 $6,727,966 $-1,491,365,708
Total Unusual Items Excluding Goodwill $-45,974,432 $-10,091,948 $6,727,966 $-1,491,365,708
Reconciled Depreciation $1,260,372,222 $1,557,524,036 $1,413,994,104 $1,796,366,815
EBITDA (Bullshit earnings) $2,915,451,760 $2,073,334,732 $1,167,302,032 $128,952,674
EBIT $1,655,079,538 $515,810,696 $-246,692,072 $-1,667,414,141
Diluted Average Shares $1,079,281,179 $1,046,614,663 $1,063,899,649 $1,068,016,811
Basic Average Shares $1,063,286,562 $1,046,614,663 $1,063,899,649 $1,068,016,811
Diluted NI Availto Com Stockholders $1,003,588,202 $-787,171,975 $-522,538,662 $-1,803,094,781
Minority Interests $-1,121,328 $-3,363,983 $-2,242,655 $-3,363,983
Tax Provision $316,214,383 $1,079,838,479 $-81,856,915 $-126,710,019
Gain On Sale Of Ppe $1,121,328 $3,363,983 $12,334,604 $2,242,655
Gain On Sale Of Business $-28,033,190 $14,577,259 $56,066,380 $4,485,310
Impairment Of Capital Assets $0 $0 $8,970,621 $1,521,641,553
Gain On Sale Of Security $-19,062,569 $-28,033,190 $-52,702,397 $23,547,880
Research And Development $1,906,256,920 $1,958,959,317 $2,119,309,164 $2,344,696,012
Selling General And Administration $5,572,998,172 $5,682,888,277 $5,754,653,243 $5,934,065,659
Other Gand A $704,193,733 $652,612,663 $681,767,181 $752,410,820
Fetched: 2026-10-25
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-990,132,271 $-1,525,005,536 $-1,166,180,704 $-577,483,714
Total Assets $30,213,050,854 $32,491,588,538 $32,973,759,406 $34,411,301,389
Total Non Current Assets $19,076,025,131 $21,254,764,658 $21,827,763,062 $22,907,601,540
Other Non Current Assets $133,437,984 $137,923,295 $102,040,812 $109,890,105
Non Current Deferred Assets $1,988,113,835 $2,148,463,682 $2,945,727,605 $2,746,131,292
Non Current Deferred Taxes Assets $1,988,113,835 $2,148,463,682 $2,945,727,605 $2,746,131,292
Non Current Accounts Receivable $235,478,796 $233,236,141 $216,416,227 $312,850,400
Investmentin Financial Assets $789,414,630 $708,679,043 $694,101,784 $740,076,216
Financial Assets Designatedas Fair Value Through Profitor Loss Total $426,104,488 $322,942,349 $318,457,038 $361,067,487
Goodwill And Other Intangible Assets $13,276,518,784 $14,987,664,702 $14,653,509,077 $15,433,953,086
Other Intangible Assets $2,880,690,604 $3,344,920,231 $3,578,156,372 $3,953,801,118
Current Assets $11,137,025,723 $11,237,945,207 $11,145,996,344 $11,503,699,848
Other Current Assets $-5,606,638 $1,121,328 $5,606,638 -
Hedging Assets Current $90,827,536 $77,371,604 $50,459,742 $137,923,295
Assets Held For Sale Current $75,128,949 $0 $88,584,880 $86,342,225
Prepaid Assets $201,838,968 $266,875,969 $220,901,537 $195,111,002
Inventory $3,218,210,212 $3,586,005,665 $3,914,554,652 $4,540,255,452
Receivables $4,423,637,382 $4,614,263,074 $4,766,763,628 $5,217,537,323
Other Receivables $590,939,645 $541,601,231 $523,659,989 $610,002,214
Taxes Receivable $67,279,656 $105,404,794 $246,692,072 $248,934,727
Accounts Receivable $3,744,112,856 $3,939,223,859 $3,976,227,670 $4,296,927,363
Allowance For Doubtful Accounts Receivable $-216,416,227 $-274,725,262 $-274,725,262 $-253,420,038
Gross Accounts Receivable $3,960,529,083 $4,213,949,121 $4,250,952,932 $4,550,347,401
Cash Cash Equivalents And Short Term Investments $3,132,989,314 $2,692,307,568 $2,099,125,267 $1,326,530,551
Cash And Cash Equivalents $3,132,989,314 $2,692,307,568 $2,095,761,284 $1,314,195,947
Cash Equivalents $2,339,089,374 $2,182,103,510 $1,568,737,312 $540,479,903
Cash Financial $793,899,941 $510,204,058 $527,023,972 $773,716,044
Financial Assets - $8,970,621 $3,363,983 $4,485,310
Debt
Net Debt $4,544,740,763 $4,504,372,969 $4,876,653,732 $5,705,314,829
Total Debt $8,758,689,884 $8,399,865,052 $8,177,842,187 $8,232,787,239
Long Term Debt And Capital Lease Obligation $7,637,362,284 $7,903,116,925 $7,803,318,768 $7,868,355,769
Long Term Debt $6,788,517,290 $6,945,503,154 $6,834,491,722 $6,912,984,654
Current Debt And Capital Lease Obligation $1,121,327,600 $496,748,127 $374,523,418 $364,431,470
Current Debt $889,212,787 $251,177,382 $137,923,295 $106,526,122
Other Current Borrowings $830,903,752 $148,015,243 $1,121,328 $6,727,966
Liabilities
Total Liabilities Net Minority Interest $17,890,781,858 $18,987,440,251 $19,449,427,222 $19,516,706,878
Total Non Current Liabilities Net Minority Interest $9,468,490,254 $9,855,348,276 $10,158,106,728 $10,620,093,700
Other Non Current Liabilities $49,338,414 $187,261,709 $62,794,346 $67,279,656
Derivative Product Liabilities $137,923,295 $74,007,622 $88,584,880 $287,059,866
Non Current Deferred Liabilities $617,851,508 $574,119,731 $605,516,904 $679,524,526
Non Current Deferred Taxes Liabilities $104,283,467 $90,827,536 $79,614,260 $102,040,812
Current Liabilities $8,422,291,604 $9,132,091,974 $9,291,320,494 $8,896,613,178
Other Current Liabilities $359,946,160 $236,600,124 $524,781,317 $1,046,198,651
Current Deferred Liabilities $1,670,778,124 $1,905,135,592 $2,028,481,628 $1,901,771,610
Payables And Accrued Expenses $4,471,854,469 $4,276,743,466 $4,723,031,851 $4,442,699,951
Interest Payable $106,526,122 $93,070,191 $85,220,898 $79,614,260
Payables $2,524,108,428 $2,278,537,683 $2,413,096,995 $2,380,578,495
Other Payable $19,062,569 $17,941,242 $13,455,931 $8,970,621
Total Tax Payable $344,247,573 $208,566,934 $237,721,451 $173,805,778
Income Tax Payable $195,111,002 $79,614,260 $93,070,191 $44,853,104
Accounts Payable $2,160,798,285 $2,052,029,508 $2,149,585,009 $2,206,772,717
Tradeand Other Payables Non Current - $133,437,984 $437,317,764 $487,777,506
Dividends Payable - $0 $12,334,604 $0
Equity
Common Stock Equity $12,286,386,513 $13,462,659,166 $13,487,328,373 $14,856,469,372
Total Equity Gross Minority Interest $12,322,268,996 $13,504,148,287 $13,524,332,184 $14,894,594,511
Stockholders Equity $12,286,386,513 $13,462,659,166 $13,487,328,373 $14,856,469,372
Other Equity Interest $-17,941,242 $-113,254,088 $-1,121,328 $1,121,328
Gains Losses Not Affecting Retained Earnings $326,306,332 $2,158,555,630 $985,646,960 $1,668,535,469
Other Equity Adjustments $-62,794,346 $-99,798,156 $6,727,966 $-2,242,655
Retained Earnings $4,008,746,170 $4,092,845,740 $6,057,411,695 $7,660,910,163
Long Term Equity Investment $165,956,485 $288,181,193 $427,225,816 $602,152,921
Other
Treasury Shares Number $13,042,383 $16,741,769 $8,248,295 $8,785,103
Ordinary Shares Number $1,066,706,537 $1,037,238,205 $1,051,100,889 $1,067,852,694
Share Issued $1,079,748,921 $1,053,979,974 $1,059,349,184 $1,067,852,694
Tangible Book Value $-990,132,271 $-1,525,005,536 $-1,166,180,704 $-577,483,714
Invested Capital $19,964,116,590 $20,659,339,702 $20,459,743,390 $21,875,980,148
Working Capital $2,714,734,120 $2,105,853,233 $1,854,675,850 $2,607,086,670
Capital Lease Obligations $1,080,959,806 $1,203,184,515 $1,205,427,170 $1,213,276,463
Total Capitalization $19,074,903,804 $20,408,162,320 $20,321,820,095 $21,769,454,026
Minority Interest $35,882,483 $41,489,121 $37,003,811 $38,125,138
Foreign Currency Translation Adjustments $389,100,677 $2,258,353,786 $1,416,236,759 $2,092,397,302
Treasury Stock $334,155,625 $460,865,644 $293,787,831 $308,365,090
Additional Paid In Capital $8,087,014,651 $7,574,567,938 $6,533,975,925 $5,634,671,190
Capital Stock $216,416,227 $210,809,589 $205,202,951 $199,596,313
Common Stock $216,416,227 $210,809,589 $205,202,951 $199,596,313
Non Current Deferred Revenue $513,568,041 $483,292,196 $525,902,644 $577,483,714
Long Term Capital Lease Obligation $848,844,993 $957,613,770 $968,827,046 $955,371,115
Long Term Provisions $1,026,014,754 $1,116,842,290 $1,160,574,066 $1,230,096,377
Current Deferred Revenue $1,670,778,124 $1,905,135,592 $2,028,481,628 $1,901,771,610
Current Capital Lease Obligation $232,114,813 $245,570,744 $236,600,124 $257,905,348
Line Of Credit $58,309,035 $103,162,139 $136,801,967 $99,798,156
Current Provisions $798,385,251 $2,216,864,665 $1,640,502,279 $1,141,511,497
Current Accrued Expenses $1,947,746,041 $1,998,205,783 $2,309,934,856 $2,062,121,456
Investments And Advances $955,371,115 $996,860,236 $1,121,327,600 $1,342,229,137
Available For Sale Securities $363,310,142 $385,736,694 $375,644,746 $379,008,729
Investmentsin Associatesat Cost $165,956,485 $288,181,193 $427,225,816 $602,152,921
Goodwill $10,395,828,180 $11,642,744,471 $11,075,352,705 $11,480,151,969
Net PPE $2,487,104,617 $2,750,616,603 $2,785,377,758 $2,958,062,209
Accumulated Depreciation $-4,154,518,758 $-4,472,975,796 $-4,126,485,568 $-4,046,871,308
Gross PPE $6,641,623,375 $7,223,592,399 $6,911,863,326 $7,006,054,845
Leases $1,489,123,053 $1,639,380,951 $1,597,891,830 $1,530,612,174
Construction In Progress $307,243,762 $303,879,780 $307,243,762 $346,490,228
Other Properties $1,868,131,782 $1,982,507,197 $1,816,550,712 $1,861,403,816
Machinery Furniture Equipment $1,738,057,780 $2,007,176,404 $1,941,018,076 $1,994,841,800
Land And Improvements $1,239,066,998 $1,290,648,068 $1,249,158,946 $1,272,706,826
Properties $0 $0 $0 $0
Finished Goods $1,443,148,621 $1,613,590,416 $1,826,642,660 $2,085,669,336
Work In Process $457,501,661 $464,229,626 $618,972,835 $726,620,285
Raw Materials $1,317,559,930 $1,507,064,294 $1,467,817,828 $1,727,965,832
Duefrom Related Parties Current $21,305,224 $28,033,190 $20,183,897 $61,673,018
Other Inventories - $1,121,328 $1,121,328 -
Other Short Term Investments - $2,242,655 $3,363,983 $12,334,604
Unrealized Gain Loss - - $-437,317,764 $-421,619,178
Held To Maturity Securities - - - $60,551,690
Fetched: 2026-10-25
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $565,149,110 $1,001,345,547 $1,673,020,779 $-1,097,779,720
Operating Activities
Operating Cash Flow $1,314,195,947 $1,759,363,004 $2,395,155,754 $-193,989,675
Cash Flow From Continuing Operating Activities $1,311,953,292 $1,759,363,004 $2,394,034,426 $-193,989,675
Operating Gains Losses $35,882,483 $119,982,053 $40,367,794 $-3,363,983
Investing Activities
Capital Expenditure $-749,046,837 $-758,017,458 $-722,134,974 $-903,790,046
Investing Cash Flow $-826,418,441 $-642,520,715 $-713,164,354 $-1,667,414,141
Cash Flow From Continuing Investing Activities $-825,297,114 $-642,520,715 $-714,285,681 $-1,666,292,814
Net Other Investing Changes $-1,121,328 - $1,121,328 $-1,121,328
Capital Expenditure Reported $-596,546,283 $-625,700,801 $-614,487,525 $-786,050,648
Financing Activities
Repurchase Of Capital Stock $0 $-460,865,644 $-742,318,871 $-209,688,261
Issuance Of Capital Stock $14,577,259 $0 $0 $13,455,931
Financing Cash Flow $119,982,053 $-556,178,490 $-950,885,805 $560,663,800
Cash Flow From Continuing Financing Activities $119,982,053 $-557,299,817 $-950,885,805 $558,421,145
Net Other Financing Charges $-2,242,655 $-1,121,328 $-3,363,983 $-4,485,310
Cash Dividends Paid $-367,795,453 $-1,121,328 $-2,242,655 $-461,986,971
Common Stock Dividend Paid $-367,795,453 $-1,121,328 $-2,242,655 $-461,986,971
Net Common Stock Issuance $14,577,259 $-460,865,644 $-742,318,871 $-196,232,330
Common Stock Issuance $14,577,259 $0 $0 $13,455,931
Dividend Received Cfo $14,577,259 $8,970,621 $14,577,259 $13,455,931
Other
Repayment Of Debt $-682,888,508 $-855,572,959 $-845,481,010 $-1,650,594,227
Issuance Of Debt $1,185,243,273 $796,142,596 $610,002,214 $2,821,260,242
End Cash Position $3,132,989,314 $2,692,307,568 $2,095,761,284 $1,314,195,947
Beginning Cash Position $2,692,307,568 $2,095,761,284 $1,314,195,947 $2,582,417,463
Effect Of Exchange Rate Changes $-155,864,536 $50,459,742 $-88,584,880 $45,974,432
Changes In Cash $596,546,283 $546,086,541 $870,150,218 $-1,314,195,947
Cash Flow From Discontinued Operation $-11,213,276 $-14,577,259 $137,923,295 $-13,455,931
Common Stock Payments $0 $-460,865,644 $-742,318,871 $-209,688,261
Net Issuance Payments Of Debt $475,442,902 $-93,070,191 $-202,960,296 $1,223,368,412
Net Short Term Debt Issuance $-26,911,862 $-33,639,828 $32,518,500 $52,702,397
Net Long Term Debt Issuance $502,354,765 $-59,430,363 $-235,478,796 $1,170,666,014
Long Term Debt Payments $-682,888,508 $-855,572,959 $-845,481,010 $-1,650,594,227
Long Term Debt Issuance $1,185,243,273 $796,142,596 $610,002,214 $2,821,260,242
Net Investment Purchase And Sale $-58,309,035 $-31,397,173 $-100,919,484 $-123,346,036
Sale Of Investment $68,400,984 $106,526,122 $53,823,725 $87,463,553
Purchase Of Investment $-126,710,019 $-137,923,295 $-154,743,209 $-210,809,589
Net Business Purchase And Sale $-28,033,190 $132,316,657 $7,849,293 $-659,340,629
Purchase Of Business $-28,033,190 $-8,970,621 $-81,856,915 $-798,385,251
Net Intangibles Purchase And Sale $-152,500,554 $-132,316,657 $-107,647,450 $-117,739,398
Purchase Of Intangibles $-152,500,554 $-132,316,657 $-107,647,450 $-117,739,398
Net PPE Purchase And Sale $10,091,948 $14,577,259 $100,919,484 $20,183,897
Sale Of PPE $10,091,948 $14,577,259 $100,919,484 $20,183,897
Taxes Refund Paid $-238,842,779 $-193,989,675 $-170,441,795 $-373,402,091
Interest Received Cfo $93,070,191 $93,070,191 $59,430,363 $16,819,914
Interest Paid Cfo $-283,695,883 $-292,666,504 $-280,331,900 $-229,872,158
Change In Working Capital $-1,381,475,603 $-105,404,794 $1,417,358,086 $-1,282,798,774
Change In Other Working Capital $-1,362,413,034 $354,339,522 $473,200,247 $-223,144,192
Change In Other Current Liabilities $60,551,690 $-57,187,708 $-42,610,449 $-94,191,518
Change In Payables And Accrued Expense $108,768,777 $-653,733,991 $401,435,281 $58,309,035
Change In Payable $108,768,777 $-653,733,991 $401,435,281 $58,309,035
Change In Account Payable $108,768,777 $-653,733,991 $401,435,281 $58,309,035
Change In Inventory $-128,952,674 $257,905,348 $288,181,193 $-641,399,387
Change In Receivables $-59,430,363 $-6,727,966 $297,151,814 $-382,372,712
Changes In Account Receivables $-10,091,948 $-1,121,328 $334,155,625 $-383,494,039
Other Non Cash Items $329,670,314 $325,185,004 $380,130,056 $181,655,071
Stock Based Compensation $158,107,192 $107,647,450 $98,676,829 $106,526,122
Asset Impairment Charge $0 $0 $8,970,621 $1,521,641,553
Deferred Tax $316,214,383 $1,080,959,806 $-79,614,260 $-126,710,019
Deferred Income Tax $316,214,383 $1,080,959,806 $-79,614,260 $-126,710,019
Depreciation Amortization Depletion $1,260,372,222 $1,557,524,036 $1,413,994,104 $1,796,366,815
Depreciation And Amortization $1,260,372,222 $1,557,524,036 $1,413,994,104 $1,796,366,815
Amortization Cash Flow $585,333,007 $777,080,027 $641,399,387 $999,102,892
Amortization Of Intangibles $585,333,007 $777,080,027 $641,399,387 $999,102,892
Depreciation $675,039,215 $780,444,010 $772,594,716 $797,263,924
Earnings Losses From Equity Investments $10,091,948 $141,287,278 $119,982,053 $125,588,691
Net Income From Continuing Operations $1,010,316,168 $-941,915,184 $-507,961,403 $-1,814,308,057
Sale Of Business - $141,287,278 $89,706,208 $139,044,622
Fetched: 2026-10-25